drugset / Trial / NCT03980756

A Study to Compare PK, PD and Safety of the AD-206 and Esomeprazole

NCT03980756

Phase 1 Completed 88 enrolled Addpharma Inc.
RandomizedCrossoverOpen-labelTreatment

Summary

A study to compare safety, pharmacokinetics and pharmacodynamics of AD-206 to Esomeprazole in healthy male volunteers.

Timeline

Start
2019-06-05
Primary completion
2020-04-27
Completion
2020-06-18

Drugs

EvaluationDrugModalityDoseRoute
Subject AD-206 Unknown 20 mg
Subject AD-206 Unknown 40 mg
Subject Esomeprazole Small molecule 20 mg
Subject Esomeprazole Small molecule 40 mg

Indications